Côte d'Ivoire vs Samoa: Prevalence rate of hypertension in women aged 30-79
Côte d'Ivoire
37.6
in 2019
Samoa
37.9
in 2019
Côte d'Ivoire rank
104th
Samoa rank
102nd
Prevalence rate of hypertension in women aged 30-79 over time
- Côte d'Ivoire
- Samoa
How they compare
Samoa currently reports 37.9 against 37.6 in Côte d'Ivoire, a difference of 0.3.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 104th and Samoa ranks 102nd of 195 countries.
Côte d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Samoa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 35.29 | 28.56 | 6.73 | Côte d'Ivoire |
| 2000s | 36.78 | 30.57 | 6.21 | Côte d'Ivoire |
| 2010s | 37.63 | 35.7 | 1.93 | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Côte d'Ivoire or Samoa?
- Samoa, at 37.9 against 37.6 in Côte d'Ivoire as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Côte d'Ivoire and Samoa?
- 0.3, with Samoa ahead.
- How many years of comparable data are there for Côte d'Ivoire and Samoa?
- 30 years are reported by both, from 1990 to 2019.
- How do Côte d'Ivoire and Samoa rank globally for prevalence rate of hypertension in women aged 30-79?
- Côte d'Ivoire ranks 104th and Samoa ranks 102nd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.